1. An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics. Issue 3 (10th May 2018) Authors: Li, Yan; Wang, Xiaomin; Liu, Liangang; Zhang, Chengyue; Gomez, Diana; Reyes, Josephine; Palmisano, Maria; Zhou, Simon Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus. Issue 10 (26th June 2018) Authors: Schafer, Peter H; Ye, Ying; Wu, Lei; Kosek, Jolanta; Ringheim, Garth; Yang, Zhihong; Liu, Liangang; Thomas, Michael; Palmisano, Maria; Chopra, Rajesh Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 10(2018) Page Start: 1516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concentration‐QTc Modeling of Ozanimod's Major Active Metabolites in Adult Healthy Subjects. (5th January 2021) Authors: Briggs, Emily; Chapel, Sunny; Zhang, Peijin; Palmisano, Maria; Tran, Jonathan Q. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 2(2021) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects. (6th June 2019) Authors: Ogasawara, Ken; MacGorman, Kimberly; Liu, Liangang; Chen, Jian; Carayannopoulos, Leonidas N.; Zhou, Simon; Palmisano, Maria; Li, Yan Journal: Journal of clinical pharmacology Issue: Volume 59:Number 12(2019) Page Start: 1620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the Potential for QTc Prolongation With Repeated Oral Doses of Fedratinib in Patients With Advanced Solid Tumors. Issue 4 (16th July 2020) Authors: Ogasawara, Ken; Xu, Christine; Yin, Jian; Darpo, Borje; Carayannopoulos, Leon; Xue, Hongqi; Palmisano, Maria; Krishna, Gopal Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 4(2021) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator. Issue 5 (23rd September 2020) Authors: Ye, Ying; Gaudy, Allison; Schafer, Peter; Thomas, Michael; Weiss, Daniel; Chen, Nianhang; Liu, Liangang; Xue, Yongjun; Carayannopoulos, Leon; Palmisano, Maria Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of Renal Impairment on the Pharmacokinetics of Apremilast and Metabolite M12. Issue 6 (6th May 2016) Authors: Liu, Yong; Zhou, Simon; Assaf, Mahmoud; Nissel, Jim; Palmisano, Maria Journal: Clinical pharmacology in drug development Issue: Volume 5:Issue 6(2016:Nov./Dec.) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects. (15th May 2018) Authors: Li, Yan; Liu, Liangang; Wang, Xiaomin; Zhang, Chengyue; Reyes, Josephine; Hoffmann, Matthew; Palmisano, Maria; Zhou, Simon Journal: Journal of clinical pharmacology Issue: Volume 58:Number 10(2018) Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers. Issue 1 (2nd September 2016) Authors: van der Velden, Jos L. J.; Ye, Ying; Nolin, James D.; Hoffman, Sidra M.; Chapman, David G.; Lahue, Karolyn G.; Abdalla, Sarah; Chen, Peng; Liu, Yong; Bennett, Brydon; Khalil, Nasreen; Sutherland, Donna; Smith, William; Horan, Gerald; Assaf, Mahmoud; Horowitz, Zebulun; Chopra, Rajesh; Stevens, Ran... Journal: Clinical and translational medicine Issue: Volume 5:Issue 1(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lenalidomide at Therapeutic and Supratherapeutic Doses Does Not Prolong QTc Intervals in the Thorough QTc Study Conducted in Healthy Men. (20th June 2013) Authors: Chen, Nianhang; Ye, Ying; Liu, Liangang; Reyes, Josephine; Assaf, Mahmoud S.; Kasserra, Claudia; Zhou, Simon; Palmisano, Maria Journal: Basic & clinical pharmacology & toxicology Issue: Volume 113:Number 3(2013) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗